{
    "2021-02-03": [
        [
            {
                "time": "2021-02-15",
                "original_text": "Vaxart Stock Crashes After Oral Covid Vaccine Fails To Produce Antibodies",
                "features": {
                    "keywords": [
                        "Vaxart",
                        "Stock",
                        "Crashes",
                        "Oral",
                        "Covid",
                        "Vaccine",
                        "Fails",
                        "Antibodies"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-16",
                "original_text": "On-demand-dental company Medbar pivots model to become COVID-19 medical service",
                "features": {
                    "keywords": [
                        "On-demand-dental",
                        "Medbar",
                        "pivots",
                        "model",
                        "COVID-19",
                        "medical",
                        "service"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "dentistry"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-17",
                "original_text": "Pfizer Is Ready, Even For COVID-19 Variants",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Ready",
                        "COVID-19",
                        "Variants"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-18",
                "original_text": "Doctor on COVID-19 progress: 'Weâ€™re definitely not out of the woods yet'",
                "features": {
                    "keywords": [
                        "Doctor",
                        "COVID-19",
                        "progress",
                        "not out of the woods"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-19",
                "original_text": "Coronavirus update: US hits 1M shots per day average as scientists eye second generation COVID-19 vaccines",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "US",
                        "1M shots",
                        "second generation",
                        "vaccines"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-20",
                "original_text": "Lifted by a Short Squeeze, Vaxart Stock Sinks on Lackluster Vaccine News",
                "features": {
                    "keywords": [
                        "Short Squeeze",
                        "Vaxart",
                        "Stock",
                        "Sinks",
                        "Lackluster",
                        "Vaccine",
                        "News"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-21",
                "original_text": "Switzerland Declines To Approve AstraZeneca COVID-19 Vaccine - Financial Times",
                "features": {
                    "keywords": [
                        "Switzerland",
                        "Declines",
                        "AstraZeneca",
                        "COVID-19",
                        "Vaccine",
                        "Financial Times"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-22",
                "original_text": "U.S. Scrambles to Overcome Its Vaccine Shortage",
                "features": {
                    "keywords": [
                        "U.S.",
                        "Scrambles",
                        "Vaccine",
                        "Shortage"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-23",
                "original_text": "GlaxoSmithKline Will Develop Next-Generation Vaccine With Biotech CureVac",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "Next-Generation",
                        "Vaccine",
                        "Biotech",
                        "CureVac"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-24",
                "original_text": "Serbians free to pick their vaccine amid plentiful supply",
                "features": {
                    "keywords": [
                        "Serbians",
                        "free",
                        "pick",
                        "vaccine",
                        "plentiful",
                        "supply"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}